The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer
Open accessAbstract
MicroRNAs (miRNAs) are single-stranded, non-coding RNA molecules that regulate gene expression post-transcriptionally by binding to messenger RNAs. miRNAs are important regulators of gene expression, and their dysregulation is implicated in many human and canine diseases. Most cancers tested to date have been shown to express altered miRNA levels, which indicates their potential importance in the oncogenic process. Based on this evidence, numerous miRNAs have been suggested as potential cancer biomarkers for both diagnosis and prognosis. miRNA-based therapies have also been tested in different cancers and have provided measurable clinical benefits to patients. In addition, understanding miRNA biogenesis and regulatory mechanisms in cancer can provide important knowledge about resistance to chemotherapies, leading to more personalized cancer treatment. In this review, we comprehensively summarized the importance of miRNA in human and canine cancer research. We discussed the current state of development and potential for the miRNA as both a diagnostic marker and a therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhai, Z., Mu, T., Zhao, L., Li, Y., Zhu, D., & Pan, Y. (2021) · Bioengineered · doi:10.1080/21655979.2021.2006974 · Cited by 61
RetractedValadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834 · cited 1×
“Circulatory exosomal miRNAs have been identified as possible disease biomarkers as they are stable in blood and are protected from endogenous RNAse activity [5].”
BackgroundMicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
miR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
Regulation of mRNA Translation and Stability by microRNAs
Fabian, M. R., Sonenberg, N., & Filipowicz, W. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060308-103103 · Cited by 3,214
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023 · cited 1×
“Low levels of expression of the let-7 miRNA family and high levels of miR-155 showed a correlation with poor prognosis in lung cancer [108].”
BackgroundExperimental and Therapeutic Medicine
(2026) · Experimental and Therapeutic Medicine · doi:10.3892/etm · Cited by 1,728
Si, M.-L., Zhu, S., Wu, H., Lu, Z., Wu, F., & Mo, Y.-Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210083 · Cited by 1,600
MicroRNA: Biogenesis, Function and Role in Cancer
MacFarlane, L.-A., & R. Murphy, P. (2010) · Current Genomics · doi:10.2174/138920210793175895 · Cited by 1,584
Schetter, A. J., Leung, S. Y., Sohn, J. J., Zanetti, K. A., Bowman, E. D., Yanaihara, N., Yuen, S. T., Chan, T. L., Kwong, D. L. W., Au, G. K. H., et al. (2008) · JAMA · doi:10.1001/jama.299.4.425 · Cited by 1,578
Hayashita, Y., Osada, H., Tatematsu, Y., Yamada, H., Yanagisawa, K., Tomida, S., Yatabe, Y., Kawahara, K., Sekido, Y., & Takahashi, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2352 · Cited by 1,511
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues
Liu, C.-G., Calin, G. A., Meloon, B., Gamliel, N., Sevignani, C., Ferracin, M., Dumitru, C. D., Shimizu, M., Zupo, S., Dono, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403293101 · Cited by 948
Mogilyansky, E., & Rigoutsos, I. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.125 · Cited by 889 · cited 2×
“Genes 2023, 14, x FOR PEER REVIEW 3 of 19 The miR-17-92 cluster (miRs-17, -18a, -19a, -20a, -19b, and -92a) downregulates PTEN (phosphate and tensin homolog), E2F, the transforming growth factor-β (TGF-β) signaling pathway, B cell lymphoma/leukemia 2-like protein 11 (BCL2L11), and thrombospondin-1 (TSP-1) [8].”
BackgroundSuppression of non-small cell lung tumor development by the let-7 microRNA family
Kumar, M. S., Erkeland, S. J., Pester, R. E., Chen, C. Y., Ebert, M. S., Sharp, P. A., & Jacks, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712321105 · Cited by 843
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
Cheng, C. J., Bahal, R., Babar, I. A., Pincus, Z., Barrera, F., Liu, C., Svoronos, A., Braddock, D. T., Glazer, P. M., Engelman, D. M., et al. (2015) · Nature · doi:10.1038/nature13905 · Cited by 823
MicroRNAs accurately identify cancer tissue origin
Rosenfeld, N., Aharonov, R., Meiri, E., Rosenwald, S., Spector, Y., Zepeniuk, M., Benjamin, H., Shabes, N., Tabak, S., Levy, A., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1392 · Cited by 812
Circulating Exosomal microRNAs as Biomarkers of Colon Cancer
Ogata-Kawata, H., Izumiya, M., Kurioka, D., Honma, Y., Yamada, Y., Furuta, K., Gunji, T., Ohta, H., Okamoto, H., Sonoda, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092921 · Cited by 809 · cited 1×
“An increase in the expression of exosomal miR-23a and miR-1246 allows the detection of disease in its early stages and differentiates between healthy and malignant tissues in colon cancer [117].”
BackgroundOncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer
Svoronos, A. A., Engelman, D. M., & Slack, F. J. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0359 · Cited by 791
MicroRNA Signature Predicts Survival and Relapse in Lung Cancer
Yu, S.-L., Chen, H.-Y., Chang, G.-C., Chen, C.-Y., Chen, H.-W., Singh, S., Cheng, C.-L., Yu, C.-J., Lee, Y.-C., Chen, H.-S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.008 · Cited by 783
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
Ma, L., Reinhardt, F., Pan, E., Soutschek, J., Bhat, B., Marcusson, E. G., Teruya-Feldstein, J., Bell, G. W., & Weinberg, R. A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1618 · Cited by 772
miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
Xia, L., Zhang, D., Du, R., Pan, Y., Zhao, L., Sun, S., Hong, L., Liu, J., & Fan, D. (2008) · International Journal of Cancer · doi:10.1002/ijc.23501 · Cited by 711
miR-221 overexpression contributes to liver tumorigenesis
Pineau, P., Volinia, S., McJunkin, K., Marchio, A., Battiston, C., Terris, B., Mazzaferro, V., Lowe, S. W., Croce, C. M., & Dejean, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907904107 · Cited by 699
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Ji, Q., Hao, X., Zhang, M., Tang, W., Yang, M., Li, L., Xiang, D., DeSano, J. T., Bommer, G. T., Fan, D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006816 · Cited by 689
Serum miR-21 as a Diagnostic and Prognostic Biomarker in Colorectal Cancer
Toiyama, Y., Takahashi, M., Hur, K., Nagasaka, T., Tanaka, K., Inoue, Y., Kusunoki, M., Boland, C. R., & Goel, A. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt101 · Cited by 499
Pairing beyond the Seed Supports MicroRNA Targeting Specificity
Broughton, J. P., Lovci, M. T., Huang, J. L., Yeo, G. W., & Pasquinelli, A. E. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.09.004 · Cited by 487
miR-21 plays a pivotal role in gastric cancer pathogenesis and progression
Zhang, Z., Li, Z., Gao, C., Chen, P., Chen, J., Liu, W., Xiao, S., & Lu, H. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.94 · Cited by 477
miRNA: A Promising Therapeutic Target in Cancer
Menon, A., Abd-Aziz, N., Khalid, K., Poh, C. L., & Naidu, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911502 · Cited by 357
Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer
Yaman Agaoglu, F., Kovancilar, M., Dizdar, Y., Darendeliler, E., Holdenrieder, S., Dalay, N., & Gezer, U. (2011) · Tumor Biology · doi:10.1007/s13277-011-0154-9 · Cited by 341
Frequent Downregulation of miR-34 Family in Human Ovarian Cancers
Corney, D. C., Hwang, C.-I., Matoso, A., Vogt, M., Flesken-Nikitin, A., Godwin, A. K., Kamat, A. A., Sood, A. K., Ellenson, L. H., Hermeking, H., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2642 · Cited by 308
From Expert Review of Molecular Diagnostics
Mascaux, C., Peled, N., Garg, K., Kato, Y., Wynes, M. W., & Hirsch, F. R. (2010) · Cited by 280
miR‐92 is a key oncogenic component of the miR‐17–92 cluster in colon cancer
Tsuchida, A., Ohno, S., Wu, W., Borjigin, N., Fujita, K., Aoki, T., Ueda, S., Takanashi, M., & Kuroda, M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02081.x · Cited by 243
Oncogenic role of miR‐17‐92 cluster in anaplastic thyroid cancer cells
Takakura, S., Mitsutake, N., Nakashima, M., Namba, H., Saenko, V. A., Rogounovitch, T. I., Nakazawa, Y., Hayashi, T., Ohtsuru, A., & Yamashita, S. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00800.x · Cited by 242
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer
Musumeci, M., Coppola, V, Addario, A., Patrizii, M., Maugeri-Saccà, M., Memeo, L., Colarossi, C., Francescangeli, F., Biffoni, M., Collura, D., et al. (2011) · Oncogene · doi:10.1038/onc.2011.140 · Cited by 236
Si, H., Sun, X., Chen, Y., Cao, Y., Chen, S., Wang, H., & Hu, C. (2013) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1315-y · Cited by 236
Targeting miR-21 for the Therapy of Pancreatic Cancer
Sicard, F., Gayral, M., Lulka, H., Buscail, L., & Cordelier, P. (2013) · Molecular Therapy · doi:10.1038/mt.2013.35 · Cited by 217
Ren, Y., Zhou, X., Mei, M., Yuan, X.-B., Han, L., Wang, G.-X., Jia, Z.-F., Xu, P., Pu, P.-Y., & Kang, C.-S. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-27 · Cited by 216
Breast cancer metastasis: a microRNA story
Negrini, M., & Calin, G. A. (2008) · Breast Cancer Research · doi:10.1186/bcr1867 · Cited by 205
Bhatnagar, N., Li, X., Padi, S. K. R., Zhang, Q., Tang, M.-S., & Guo, B. (2010) · Cell Death & Disease · doi:10.1038/cddis.2010.85 · Cited by 203
Buechner, J., Tømte, E., Haug, B. H., Henriksen, J. R., Løkke, C., Flægstad, T., & Einvik, C. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.220 · Cited by 201
miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1
Wang, Y., Lieberman, R., Pan, J., Zhang, Q., Du, M., Zhang, P., Nevalainen, M., Kohli, M., Shenoy, N. K., Meng, H., et al. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0556-9 · Cited by 160
Salivary MicroRNAs as Promising Biomarkers for Detection of Esophageal Cancer
Xie, Z., Chen, G., Zhang, X., Li, D., Huang, J. J., CuiQin, Y., Zhang, P., Qin, Y., Duan, Y., Gong, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057502 · Cited by 154
Lynch, J., Fay, J., Meehan, M., Bryan, K. R., Watters, K. M., Murphy, D. M., & Stallings, R. L. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs114 · Cited by 154
Micrornas in prostate cancer: an overview
Vanacore, D., Boccellino, M., Rossetti, S., Cavaliere, C., D’Aniello, C., Franco, R. D., Romano, F. J., Montanari, M., Mantia, E. L., Piscitelli, R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16933 · Cited by 152
Teplyuk, N. M., Uhlmann, E. J., Gabriely, G., Volfovsky, N., Wang, Y., Teng, J., Karmali, P. P., Marcusson, E. G., Peter, M., Mohan, A., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505495 · Cited by 151
The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer
Chan, J. K., Blansit, K., Kiet, T. K., Sherman, A. E., Wong, G., Earle, C., & Bourguignon, L. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.01.034 · Cited by 146
Downregulation of miR‐29 contributes to cisplatin resistance of ovarian cancer cells
Yu, P., Yan, M., Lai, H., Huang, R., Chou, Y., Lin, W., Yeh, L., & Lin, Y. (2013) · International Journal of Cancer · doi:10.1002/ijc.28399 · Cited by 138
林下, 陽. (2006) · Medical Entomology and Zoology · Cited by 137
Niu, J., Xue, A., Chi, Y., Xue, J., Wang, W., Zhao, Z., Fan, M., Yang, C. H., Shao, Z.-M., Pfeffer, L. M., et al. (2015) · Oncogene · doi:10.1038/onc.2015.189 · Cited by 135
miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer
Hu, Y., Qiu, Y., Yagüe, E., Ji, W., Liu, J., & Zhang, J. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.194 · Cited by 131
Salivary MicroRNA in Pancreatic Cancer Patients
Humeau, M., Vignolle‐Vidoni, A., Sicard, F., Martins, F., Bournet, B., Buscail, L., Torrisani, J., & Cordelier, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130996 · Cited by 129
MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity
Xue, J., Chi, Y., Chen, Y., Huang, S., Ye, X., Niu, J., Wang, W., Pfeffer, L. M., Shao, Z.-M., Wu, Z.-H., et al. (2015) · Oncogene · doi:10.1038/onc.2015.96 · Cited by 128
miR-221/222: promising biomarkers for breast cancer
Chen, W., Hu, Q., Qiu, M., Zhong, S., Xu, J., Tang, J., & Zhao, J. (2013) · Tumor Biology · doi:10.1007/s13277-013-0750-y · Cited by 119
Upregulation of miR-21 in Cisplatin Resistant Ovarian Cancer via JNK-1/c-Jun Pathway
Echevarría-Vargas, I. M., Valiyeva, F., & Vivas-Mejía, P. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097094 · Cited by 118
MicroRNA expression in canine mammary cancer
Boggs, R. M., Wright, Z. M., Stickney, M., Porter, W. W., & Murphy, K. E. (2008) · Mammalian Genome · doi:10.1007/s00335-008-9128-7 · Cited by 115
Li, B., Shi, X.-B., Nori, D., Chao, C., Chen, A. M., Valicenti, R. K., & White, R. D. (2010) · The Prostate · doi:10.1002/pros.21272 · Cited by 111
Plasma miR‐122 and miR‐200 family are prognostic markers in colorectal cancer
Maierthaler, M., Benner, A., Hoffmeister, M., Surowy, H., Jansen, L., Knebel, P., Chang-Claude, J. C., Brenner, H., & Burwinkel, B. (2016) · International Journal of Cancer · doi:10.1002/ijc.30433 · Cited by 110
Wahdan-Alaswad, R. S., Cochrane, D. R., Spoelstra, N. S., Howe, E. N., Edgerton, S. M., Anderson, S. M., Thor, A. D., & Richer, J. K. (2014) · Hormones and Cancer · doi:10.1007/s12672-014-0188-8 · Cited by 108
Christensen, L. L., Tobiasen, H., Holm, A., Schepeler, T., Ostenfeld, M. S., Thorsen, K., Rasmussen, M. H., Birkenkamp‐Demtröder, K., Sieber, O. M., Gibbs, P., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28010 · Cited by 107
Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells
Báez-Vega, P. M., Vargas, I. M. E., Valiyeva, F., Encarnación-Rosado, J., Roman, A., Flores, J., Marcos-Martínez, M. J., & Vivas-Mejía, P. E. (2016) · Oncotarget · doi:10.18632/oncotarget.9216 · Cited by 107
MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers
Jackson, B. L., Grabowska, A. M., & Ratan, H. L. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-930 · Cited by 106
Bidarra, D., Constâncio, V., Barros‐Silva, D., Ramalho-Carvalho, J., Moreira-Barbosa, C., Antunes, L., Maurício, J., Oliveira, J., Henrique, R., & Jerónimo, C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00900 · Cited by 106
Xu, X., Zhu, Y., Liang, Z. C., Li, S., Xu, X., Wang, X., Wu, J., Hu, Z., Meng, S., Liu, B., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2015.274 · Cited by 105
MiR-17-92 cluster promotes hepatocarcinogenesis
Zhu, H., Han, C., & Wu, T. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv112 · Cited by 104
Circulating miR-21 as novel biomarker in gastric cancer
Simonian, M., Mosallayi, M., & Mirzaei, H. (2018) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.175428 · Cited by 103
MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma
Sarver, A. L., Thayanithy, V., Scott, M. C., Cleton-Jansen, A., Hogendoorn, P. C. W., Modiano, J. F., & Subramanian, S. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-7 · Cited by 101
Wu, Z.-H., Tao, Z., Zhang, J., Li, T., Chen, N., Xie, J., Zhang, J., & Hu, X. (2015) · Tumor Biology · doi:10.1007/s13277-015-4604-7 · Cited by 99
Ślusarz, A., & Pulakat, L. (2015) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000246 · Cited by 98
Dong, C., Wu, W. K. K., Feng, S., WANG, X. J., Shao, J., & Qiao, J. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1542 · Cited by 93
The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer
Schwarzenbach, H. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1069183 · Cited by 92
Genetic and epigenetic changes in lung carcinoma and their clinical implications
Wen, J., Fu, J., Zhang, W., & Guo, M. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.46 · Cited by 86
MicroRNA-320a promotes 5-FU resistance in human pancreatic cancer cells
Wang, W., Zhao, L., Wei, X., Wang, L., Liu, S., Yang, Y. P., Wang, F., Sun, G., Zhang, J., Ma, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep27641 · Cited by 86
Targeting MicroRNAs in Prostate Cancer Radiotherapy
Ni, J., Bucci, J. A., Chang, L., Malouf, D. J., Graham, P., & Li, Y. (2017) · Theranostics · doi:10.7150/thno.19934 · Cited by 84
The roles of microRNAs in tumorigenesis and angiogenesis.
Yang, W., Lee, D. Y., & Ben‐David, Y. (2011) · PubMed · Cited by 83
Predicting distant metastasis and chemoresistance using plasma miRNAs
Chen, J., Wang, W., Zhang, Y., Chen, Y., & Hu, T. (2013) · Medical Oncology · doi:10.1007/s12032-013-0799-x · Cited by 74
Wu, X., Cheng, Y. L., Mathew, M., Yoon, A. J., Schwartz, G. K., Bala, S., Taylor, A. M., & Momen‐Heravi, F. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01865-2 · Cited by 72
MicroRNA theragnostics for the clinical management of multiple myeloma
Ahmad, N., Haider, S. A., Jagannathan, S., Anaissie, E. J., & Driscoll, J. J. (2013) · Leukemia · doi:10.1038/leu.2013.262 · Cited by 70
MicroRNAs as Molecular Targets for Cancer Therapy: On the Modulation of MicroRNA Expression
Costa, P. M., & de Lima, M. C. P. (2013) · Pharmaceuticals · doi:10.3390/ph6101195 · Cited by 70
MicroRNA-320a inhibits breast cancer metastasis by targeting metadherin
Yu, J., Wang, J., Zhang, L., Yang, H., Wang, L., Ding, D., Chen, Q., Yang, W., Ren, K., Zhou, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9572 · Cited by 70
MicroRNA-449a enhances radiosensitivity by downregulation of c-Myc in prostate cancer cells
Mao, A., Zhao, Q., Zhou, X., Sun, C., Si, J., Zhou, R., Gan, L., & Zhang, H. (2016) · Scientific Reports · doi:10.1038/srep27346 · Cited by 69
Liu, Y., Zheng, M., Jiao, M., Yan, C., Xu, S., Du, Q., Morsch, M., Yin, J., & Shi, B. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121036 · Cited by 68
Let-7: A regulator of the ERα signaling pathway in human breast tumors and breast cancer stem cells
Sun, X., Qin, S., Fan, C., Xu, C., DU, N., & Ren, H. (2013) · Oncology Reports · doi:10.3892/or.2013.2330 · Cited by 67
Circulating microRNA-214 and -126 as potential biomarkers for canine neoplastic disease
Heishima, K., Ichikawa, Y., Yoshida, K., Iwasaki, R., Sakai, H., Nakagawa, T., Tanaka, Y., Hoshino, Y., Okamura, Y., Murakami, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02607-1 · Cited by 67
Fogli, S., Polini, B., Carpi, S., Pardini, B., Naccarati, A., Dubbini, N., Lanza, M., Breschi, M. C., Romanini, A., & Nieri, P. (2017) · Tumor Biology · doi:10.1177/1010428317701646 · Cited by 66
Dysregulation of key microRNAs in pancreatic cancer development
Baradaran, B., Shahbazi, R., & Khordadmehr, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.177 · Cited by 66
Bulkowska, M., Rybicka, A. M., Senses, K. M., Ulewicz, K., Witt, K., Szymanska, J., Taciak, B., Klopfleisch, R., Hellmén, E., Dolka, I., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3751-1 · Cited by 65
Shen, J., Wan, R., Hu, G., Yang, L., Xiong, J., Wang, F., Shen, J., He, S., Guo, X., Ni, J., et al. (2012) · Pancreatology · doi:10.1016/j.pan.2012.02.008 · Cited by 63
Alternative splicing affects the subcellular localization of Drosha
Link, S., Grund, S. E., & Diederichs, S. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw400 · Cited by 63
Strotbek, M., Schmid, S., Sánchez-González, I., Boerries, M., Busch, H. S., & Olayioye, M. A. (2017) · International Journal of Cancer · doi:10.1002/ijc.30661 · Cited by 63
Comparative Study of Anti-Oncogenic MicroRNA-145 in Canine and Human Malignant Melanoma
Noguchi, S., Mori, T., Hoshino, Y., Yamada, N. O., Nakagawa, T., Sasaki, N., Akao, Y., & Maruo, K. (2011) · Journal of Veterinary Medical Science · doi:10.1292/jvms.11-0264 · Cited by 62
Hailing, L., Wang, Y., Li, X., Zhang, Y., Li, J., Zheng, Y., Liu, M., Song, X., & Li, X. (2013) · Tumor Biology · doi:10.1007/s13277-013-0708-0 · Cited by 61
miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy
Nagesh, P. K. B., Chowdhury, P., Hatami, E., Boya, V. K. N., Kashyap, V. K., Khan, S., Hafeez, B. B., Chauhan, S. C., Jaggi, M., & Yallapu, M. M. (2018) · Cancers · doi:10.3390/cancers10090289 · Cited by 56
Circulating microRNA as biomarkers of canine mammary carcinoma in dogs
Fish, E. J., Martinez-Romero, E. G., DeInnocentes, P., Koehler, J. W., Prasad, N., Smith, A. N., & Bird, R. (2020) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15764 · Cited by 56
microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression
Tong, S., Liu, J., Wang, X., & Qu, L. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1846 · Cited by 55
Malignancy Associated MicroRNA Expression Changes in Canine Mammary Cancer of Different Malignancies
von Deetzen, M.-C., Schmeck, B., Gruber, A. D., & Klopfleisch, R. (2014) · ISRN Veterinary Science · doi:10.1155/2014/148597 · Cited by 54
Epigenetic Targets and their Inhibitors in Cancer Therapy
Zhao, L., Duan, Y., Lü, P., Zhang, Z., Zheng, X., Wang, J., & Feng, W. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666181224095449 · Cited by 54
Li, J., Kong, F., Wu, K., Song, K., He, J., & Sun, W. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2558 · Cited by 53
Breast cancer: Overview & updates
Downs-Holmes, C., & Silverman, P. (2011) · The Nurse Practitioner · doi:10.1097/01.npr.0000407602.29522.d7 · Cited by 50
Zhang, X., Wang, C., Shan, S., Liu, X., Jiang, Z., & Ren, T. (2016) · Oncotarget · doi:10.18632/oncotarget.9902 · Cited by 50
Noguchi, S., Mori, T., Hoshino, Y., Yamada, N. O., Maruo, K., & Akao, Y. (2013) · Veterinary and Comparative Oncology · doi:10.1002/vco.306 · Cited by 49
Grimes, J. A., Prasad, N., Levy, S., Cattley, R. C., Lindley, S. S., Boothe, H. W., Henderson, R. A., & Smith, B. F. (2016) · BMC Veterinary Research · doi:10.1186/s12917-016-0903-5 · Cited by 49
Self-citationFenger, J. M., Bear, M. D., Volinia, S., Lin, T., Harrington, B. K., London, C. A., & Kisseberth, W. C. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-84 · Cited by 48
Ma, T., Lu, Y., & Zhang, J. (2015) · Oncology Reports · doi:10.3892/or.2015.3713 · Cited by 47
Beaumier, A., Robinson, S. R., Robinson, N. A., Lopez, K. E., Meola, D. M., Barber, L. G., Bulmer, B. J., Calvalido, J., Rush, J. E., Yeri, A., et al. (2020) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15762 · Cited by 46
Roles of MicroRNAs in Cancers and Development
Takasaki, S. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1538-5_24 · Cited by 45
Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer
Shukla, K. K., Misra, S., Pareek, P., Mishra, V., Singhal, B., & Sharma, P. (2016) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2016.10.019 · Cited by 45
Monzó, M., Santasusagna, S., Moreno, I., Martínez-Ródenas, F., Hernández, R., Muñoz, C., Castellano, J. J., Moreno, J., & Navarro, A. (2017) · Oncotarget · doi:10.18632/oncotarget.16103 · Cited by 45
Garnica, T. K., Lesbon, J. C. C., de Ávila, A. C. F. C. M., Rochetti, A. L., Matiz, O. R. S., Ribeiro, R. C. D. S., de Zoppa, A. M., Nishiya, A. T., Tinucci‐Costa, M., Nardi, A. B. D., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77366-7 · Cited by 44
A novel circulating miRNA panel for non-invasive ovarian cancer diagnosis and prognosis
Ward, A., Witte, T., Haarhuis, L., & Schott, S. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01925-0 · Cited by 44
Fenger, J. M., Roberts, R. D., Iwenofu, O. H., Bear, M. D., Zhang, X., Couto, J. I., Modiano, J. F., Kisseberth, W. C., & London, C. A. (2016) · BMC Cancer · doi:10.1186/s12885-016-2837-5 · Cited by 43
Lyu, J., Lin, Z., Wang, F., Ji, J., Cao, Z., Xu, H., Shi, X., Zhu, Y., Zhang, C., Guo, F., et al. (2019) · BioMed Research International · doi:10.1155/2019/9306803 · Cited by 42
The role of microRNA in castration-resistant prostate cancer
Thieu, W., Tilki, D., White, R. D., & Evans, C. P. (2014) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2013.11.004 · Cited by 41
Guo, X., Han, T., Hu, P., Guo, X., Zhu, C., Wang, Y., & Chang, S. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-2009-4 · Cited by 41
Barbato, A., Iuliano, A., Volpe, M., D’Alterio, R., Brillante, S., Massa, F., Cegli, R. D., Carrella, S., Salati, M., Russo, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041801 · Cited by 41
Noguchi, S., Mori, T., Hoshino, Y., Yamada, N. O., Maruo, K., & Akao, Y. (2011) · Veterinary and Comparative Oncology · doi:10.1111/j.1476-5829.2011.00306.x · Cited by 40
Kabir, F. M. L., DeInnocentes, P., & Bird, R. C. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25243 · Cited by 39
Vinall, R. L., Kent, M. S., & White, R. D. (2012) · American Journal of Veterinary Research · doi:10.2460/ajvr.73.10.1626 · Cited by 39
MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis
Heishima, K., Mori, T., Sakai, H., Sugito, N., Murakami, M., Yamada, N. O., Akao, Y., & Maruo, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137361 · Cited by 39
A Novel Urinary miRNA Biomarker for Early Detection of Colorectal Cancer
Iwasaki, H., Shimura, T., Kitagawa, M., Yamada, T., Nishigaki, R., Fukusada, S., Okuda, Y., Katano, T., Horike, S., & Kataoka, H. (2022) · Cancers · doi:10.3390/cancers14020461 · Cited by 39
MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines
López, C. M., Yu, P. Y., Zhang, X., Yilmaz, A. S., London, C. A., & Fenger, J. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190086 · Cited by 38
Abrahamsson, A. E., & Dabrosin, C. (2015) · Oncotarget · doi:10.18632/oncotarget.4038 · Cited by 37
MicroRNA-21 as an Indicator of Aggressive Phenotype in Breast Cancer
Özgün, A., Karagöz, B., Bilgi, O., Tunçel, T., Baloğlu, H., & Kandemir, E. G. (2013) · Oncology Research and Treatment · doi:10.1159/000348678 · Cited by 37
Hozaka, Y., Seki, N., Tanaka, T., Asai, S., Moriya, S., Idichi, T., Wada, M., Tanoue, K., Kawasaki, Y., Mataki, Y., et al. (2021) · Cancers · doi:10.3390/cancers13112804 · Cited by 37
A MAPK/miR-29 Axis Suppresses Melanoma by Targeting MAFG and MYBL2
Vera, O., Bok, I., Jasani, N., Nakamura, K., Xu, X., Mecozzi, N., Angarita, A. M., Wang, K., Tsai, K. Y., & Karreth, F. A. (2021) · Cancers · doi:10.3390/cancers13061408 · Cited by 36
Immunophenotype-related microRNA expression in canine chronic lymphocytic leukemia
Gioia, G., Mortarino, M., Gelain, M. E., Albonico, F., Ciusani, E., Forno, I., Marconato, L., Martini, V., & Comazzi, S. (2011) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2011.05.020 · Cited by 34
Song, H.-J., Oh, B., Choi, M., Oh, J., & Lee, M. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2014.1000336 · Cited by 34
Song, Y., Liu, G., Pei, C., Chen, W., Li, P., Wang, Q., Jin, X., Zhu, J., Wang, M., & Liu, X. (2015) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000198 · Cited by 32
Ren, Y.-G., Zhou, X., Cui, Z., & Hou, G. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.05.02 · Cited by 32
Qu, H., Zheng, L., Song, H., Jiao, W., Li, D., Fang, E., Wang, X., Mei, H., Pu, J., Huang, K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9813 · Cited by 32
Husna, A. A., Rahman, M. M., Lai, Y., et al. (2021) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13000 · Cited by 32
Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches
Grassilli, S., Bertagnolo, V., & Brugnoli, F. (2022) · Diagnostics · doi:10.3390/diagnostics12092139 · Cited by 32
Farran, B., Dyson, G. E., Craig, D., Dombkowski, A. A., Beebe‐Dimmer, J., Powell, I. J., Podgorski, I., Heilbrun, L. K., Bolton, S., & Bock, C. H. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy025 · Cited by 30
Distinct roles of miR-34 family members on suppression of lung squamous cell carcinoma
Sun, D., Yao, W., Zhang, S., Han, Y., Shen, J., Zheng, W., Lin, W., Liu, Y., Ren, L., Gu, Z., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111967 · Cited by 26
Kent, M. S., Zwingenberger, A. L., Westropp, J. L., Barrett, L. E., Durbin-Johnson, B. P., Ghosh, P., & Vinall, R. L. (2017) · BMC Veterinary Research · doi:10.1186/s12917-017-1259-1 · Cited by 24
MiRNAs in Canine and Human Osteosarcoma: A Highlight Review on Comparative Biomolecular Aspects
Leonardi, L., Scotlandi, K., Pettinari, I., Benassi, M. S., Porcellato, I., & Pazzaglia, L. (2021) · Cells · doi:10.3390/cells10020428 · Cited by 24
Metastasis‐associated microRNA expression in canine uveal melanoma
Starkey, M., Compston-Garnett, L., Malho, P., Dunn, K., & Dubielzig, R. R. (2017) · Veterinary and Comparative Oncology · doi:10.1111/vco.12315 · Cited by 23
miR-1 and miR-133b expression in canine osteosarcoma
Leonardi, L., Pazzaglia, L., & Serena, B. M. (2017) · Research in Veterinary Science · doi:10.1016/j.rvsc.2017.12.002 · Cited by 22
Hypoxic miRNAs expression are different between primary and metastatic melanoma cells
Hino, Y., Rahman, M. M., Lai, Y., Husna, A. A., Chen, H.-W., Hasan, M. N., Nakagawa, T., & Miura, N. (2021) · Gene · doi:10.1016/j.gene.2021.145552 · Cited by 19
Alegre, F., Ormonde, A. R., Snider, K. M., Woolard, K., Yu, A., & Wittenburg, L. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209941 · Cited by 18
Narita, M., Nishida, H., Asahina, R., Nakata, K., Yano, H., Dickinson, P. J., Tanaka, T. T., Akiyoshi, H., Maeda, S., & Kamishina, H. (2020) · American Journal of Veterinary Research · doi:10.2460/ajvr.81.4.355 · Cited by 18
pH-activated DNA nanomachine for miRNA-21 imaging to accurately identify cancer cell
Yao, S., Zhao, X., Wang, L., Chen, F., Gong, H., Chen, C., & Cai, C. (2022) · Microchimica Acta · doi:10.1007/s00604-022-05340-3 · Cited by 18
Kemp, S. R. M., Komor, M. A., Hegi, R., Bolijn, A. S., Tijssen, M., de Groen, F. L. M., Depla, A. C. T. M., van Leerdam, M. E., Meijer, G. A., Fijneman, R. J. A., et al. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100820 · Cited by 14
Lu, F. Y., Zhao, X., Zhang, Z., Xiong, M., Wang, Y., Sun, Y., He, B., & Zhu, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.927079 · Cited by 10
Zamarian, V., Ferrari, R., Stefanello, D., Ceciliani, F., Grieco, V., Minozzi, G., Chiti, L. E., Arigoni, M., Calogero, R., & Lecchi, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-75877-x · Cited by 9
Dehghan, R., Najafi, R., Jalilian, F. A., Saidijam, M., Radaei, Z., Zamani, A., Ezati, R., Asnaashari, F., & Amini, R. (2021) · Molecular Biology Reports · doi:10.1007/s11033-020-06035-9 · Cited by 8
Yoshikawa, R., Mori, T., Noguchi, S., Akao, Y., Maruo, K., & Kitade, Y. (2019) · Veterinary and Comparative Oncology · doi:10.1111/vco.12485 · Cited by 7
Metadata
- Authors
- Chakrabortty, A., Patton, D. J., Smith, B. F., & Agarwal, P.
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2023-06-29
- Volume
- 14
- Issue
- 7
- Pages
- 1375
- ISSN
- 2073-4425 (ISSN-L)
- OpenAlex
- W4382725355
- Cited by
- 256
- References
- 149
- FWCI
- 24.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.